Carrozzo Giannicola, Miglis Mitchell G, Contin Manuela, Cani Ilaria, Cortelli Pietro, Guaraldi Pietro, Calandra-Buonaura Giovanna
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Biomedical and NeuroMotor Sciences (DIBINEM), Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Department of Neurology and Neurological Sciences, Stanford Medical Center, Palo Alto, CA, USA.
Auton Neurosci. 2024 Dec;256:103216. doi: 10.1016/j.autneu.2024.103216. Epub 2024 Sep 7.
Plasma levels of the catecholamine norepinephrine (NE) has emerged as a useful tool to help differentiate pre- and post-ganglionic disorders in patients with cardiovascular autonomic failure (AF). However, data on intrasubject reliability in individuals with these conditions are limited. We evaluated the intrasubject reproducibility of supine plasma NE levels drawn across two consecutive time points under controlled conditions during head-up table testing in a large cohort of patients with alpha-synucleinopathies and both pre- and post-ganglionic cardiovascular AF.
Antecubital venous blood drawn via an indwelling cannula with the subject supine was assayed for plasma level of catecholamines. We collected two consecutive samples, the first after 20 min of supine rest (NE1) and the second 5 min later (NE2), from a group of 279 participants including 57 with Parkinson's disease/Lewy body dementia (44 M; 65.5 ± 11.1 y), 131 with multiple system atrophy (81 M; 63.2 ± 8.5 y), 41 with pure autonomic failure (25 M, 65.1 ± 9.3 y), and 50 healthy controls (27 M; 46.7 ± 19.4 y).
We found no difference between NE1 and NE2 (p = 0.645), with a mean intrasubject reproducibility (NE maximum - NE minimum) × 100 / NE maximum) of 11.5 % ± 10.64. This finding was confirmed when controlling for diagnosis (p = 0.669), gender (p = 0.493), age (p = 0.865), disease duration (p = 0.596) or considering all factors together (p = 0.527).
We found excellent test-retest reliability of consecutive supine NE measurements in patients with alpha-synucleinopathies and cardiovascular AF, independent of age, gender and disease duration. This lends evidence to support the use of a single supine NE measurement in these conditions.
血浆儿茶酚胺去甲肾上腺素(NE)水平已成为帮助区分心血管自主神经功能衰竭(AF)患者节前和节后障碍的有用工具。然而,关于这些情况下个体受试者内可靠性的数据有限。我们在一大群α-突触核蛋白病患者以及节前和节后心血管AF患者的头高位试验中,在受控条件下评估了连续两个时间点采集的仰卧位血浆NE水平的受试者内再现性。
通过留置套管在受试者仰卧位时采集肘前静脉血,检测儿茶酚胺的血浆水平。我们从279名参与者中连续采集了两个样本,第一个样本在仰卧休息20分钟后采集(NE1),第二个样本在5分钟后采集(NE2),这些参与者包括57名帕金森病/路易体痴呆患者(44名男性;65.5±11.1岁)、131名多系统萎缩患者(81名男性;63.2±8.5岁)、41名纯自主神经功能衰竭患者(25名男性,65.1±9.3岁)和50名健康对照者(27名男性;46.7±19.4岁)。
我们发现NE1和NE2之间没有差异(p = 0.645),受试者内平均再现性((NE最大值 - NE最小值)×100 / NE最大值)为11.5%±10.64。在控制诊断(p = 0.669)、性别(p = 0.493)、年龄(p = 0.865)、病程(p = 0.596)或综合考虑所有因素(p = 0.527)时,这一发现得到了证实。
我们发现α-突触核蛋白病和心血管AF患者连续仰卧位NE测量具有出色的重测可靠性,且不受年龄、性别和病程影响。这为在这些情况下使用单次仰卧位NE测量提供了证据支持。